다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society, v.35 no.2, 2018년, pp.159 - 165
Cohen, Oren S. (Movement Disorders Institute, Sagol Neuroscience Center and Department of Neurology, Chaim Sheba Medical Center, Tel-Hashomer, Israel) , Rigbi, Amihai (Department of Behavioral Sciences, Beit Berl Academic College, Kfar Saba, Israel) , Yahalom, Gilad (Movement Disorders Institute, Sagol Neuroscience Center and Department of Neurology, Chaim Sheba Medical Center, Tel-Hashomer, Israel) , Warman-Alaluf, Naama (Movement Disorders Institute, Sagol Neuroscience Center and Department of Neurology, Chaim Sheba Medical Center, Tel-Hashomer, Israel) , Nitsan, Zeev (Department of Neurology, Barzilai Medical Center, Ashkelon, Israel) , Zangen, Abraham (Department of Life Sciences, Ben-Gurion University, Beer-Sheba, Israel.) , Hassin-Baer, Sharon (Movement Disorders Institute, Sagol Neuroscience Center and Department of Neurology, Chaim Sheba Medical Center, Tel-Hashomer, Israel)
PURPOSE:: To study the effects of a repetitive deep transcranial magnetic stimulation (rDTMS) in patients with Parkinson disease using the H5 coil for the low-frequency stimulation of the primary motor cortex, followed by the high-frequency rDTMS of the prefrontal cortex. METHODS:: The main outcome measures were the total and motor scores of the Unified Parkinson’s Disease Rating Scale (UPDRS). Secondary measures included rating of depression and quantitative motor tasks. RESULTS:: Forty-eight patients were randomized 1:1 into real or sham rDTMS treatment arms. Analyses (n = 42) of both UPDRS scores revealed a significant main effect for time between baseline and day 90 (end of treatment), indicating that there was an improvement of both scores over time in the whole sample. Although effects of treatment and time-by-treatment were insignificant, simple effects analysis of both measures was significant in the rDTMS group and reached a P-value of 0.06 in the sham group. The response rate was higher in patients with longer disease duration and higher motor UPDRS scores. Side effects were more common in the rDTMS group but were transient and tolerable. CONCLUSIONS:: Although rDTMS treatment exhibited some motor improvements, we could not demonstrate an advantage for real treatment over sham. Further research is required to establish stimulation parameters that may induce potentially more beneficial outcomes, probably in patients with longer and more sever disease.
Eur J Pharmacol Kakkar 750 74 2015 10.1016/j.ejphar.2015.01.030 Management of Parkinson's disease: current and future pharmacotherapy
Clin Neurophysiol Lefaucheur 125 2150 2014 10.1016/j.clinph.2014.05.021 Evidence based guidelines for the therapeutic use of repetitive transcranial stimulation
J Neurol Sci Mally 162 179 1999 10.1016/S0022-510X(98)00318-9 Improvement in Parkinsonian symptoms after repetitive transcranial magnetic stimulation
Mov Disord Lomarev 21 325 2006 10.1002/mds.20713 Placebo-controlled study of rTMS for the treatment of Parkinson's disease
J Neurol Neurosurg Psychiatry Fregni 76 1614 2005 10.1136/jnnp.2005.069849 Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta- analysis of the literature
Mov Disord Zanjani 30 750 2015 10.1002/mds.26206 Repetitive transcranial magnetic stimulation of the primary motor cortex in the treatment of motor signs in Parkinson's disease: a quantitative review of the literature
Neurology Chen 48 1398 1997 10.1212/WNL.48.5.1398 Depression of motor cortex excitability by low- frequency transcranial magnetic stimulation
Brain Priori 117 317 1994 10.1093/brain/117.2.317 Motor cortical inhibition and the dopaminergic system
Ann Neurol Ridding 37 181 1995 10.1002/ana.410370208 Changes in excitability of motor cortical circuitry in patients with Parkinson's disease
Neuroimage Menke 52 1175 2010 10.1016/j.neuroimage.2010.05.086 Connectivity-based segmentation of the substantia nigra in Parkinson's disease
Neurosci Lett Murase 157 53 1993 10.1016/0304-3940(93)90641-W Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo
J Neurochem Karreman 66 589 1996 10.1046/j.1471-4159.1996.66020589.x The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area
J Neurosci Res Arias-Carrión 84 1425 2006 10.1002/jnr.21068 Neuronal precursors within the adult rat subventricular zone differentiate into dopaminergic neurons after substantia nigra lesion and chromaffin cell transplant
J Clin Neurophysiol Roth 24 31 2007 10.1097/WNP.0b013e31802fa393 Three- dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using Figure-8 and deep H- coils
J Clin Neurophysiol Roth 19 361 2001 10.1097/00004691-200208000-00008 A coil design for transcranial magnetic stimulation of deep brain regions
Clin Neurophysiol Zangen 116 775 2005 10.1016/j.clinph.2004.11.008 Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil
Clin Neurophysiol Roth 121 255 2010 10.1016/j.clinph.2009.09.004 Motor evoked potential latency, motor threshold and electric field measurements as indices of transcranial magnetic stimulation depth
Clin Neurophysiol Roth 125 336 2014 10.1016/j.clinph.2013.07.013 Motor cortex activation by H-coil and figure-8 coil at different depths. Combined motor threshold and electric field distribution study
J Neuropsychiatry Clin Neurosci Mega 6 358 1994 10.1176/jnp.6.4.358 Frontal-subcortical circuits and neuropsychiatric disorders
Prog Neurobiol Pell 93 59 2011 10.1016/j.pneurobio.2010.10.003 Modulation of cortical excitability induced by repetitive transcranial magnetic stimulation: Influence of timing and geometrical parameters and underlying mechanisms
World Psychiatry Levkovitz 14 64 2015 10.1002/wps.20199 Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial
Mov Disord Cohen 25 suppl 2 S293 2010 Repetitive transcranial magnetic stimulation using the H-coil for Parkinson's disease
Clin Neurol Neurosurg Cohen 140 73 2016 10.1016/j.clineuro.2015.11.017 Repetitive deep transcranial magnetic stimulation for motor symptoms in Parkinson's disease: a feasibility study
J Neurol Neurosurg Psychiatry Hughes 55 181 1992 10.1136/jnnp.55.3.181 Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases
J Psychiatr Res Folstein 12 189 1775 10.1016/0022-3956(75)90026-6 Mini-mental state. A practical method for grading the cognitive state of patients for the clinician
Arch Neurol Shulman 67 64 2010 10.1001/archneurol.2009.295 The clinically important difference on the unified Parkinson's disease rating scale
Clin Neurophysiol Levkovitz 118 2730 2007 10.1016/j.clinph.2007.09.061 Deep transcranial magnetic stimulation-a randomized controlled safety and cognitive study
Arch Gen Psychiatry Beck 4 561 1961 10.1001/archpsyc.1961.01710120031004 An inventory for measuring depression
Brain Haslinger 124 558 2001 10.1093/brain/124.3.558 Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa
Clin Neurophysiol Maeda 111 800 2000 10.1016/S1388-2457(99)00323-5 Modulation of cortical excitability by repetitive transcranial magnetic stimulation
Exp Brain Res Romeo 135 504 2000 10.1007/s002210000541 Changes in the cortical silent period after repetitive magnetic stimulation of cortical motor areas
Neurology Chu 72 842 2009 10.1212/01.wnl.0000343881.27524.e8 Impaired presynaptic inhibition in the motor cortex in Parkinson's disease
Mov Disord Elahi 34 357 2009 10.1002/mds.22364 Effect of transcranial magnetic stimulation on Parkinson motor function: systematic review of controlled clinical trials
Acta Neuropsychiatr Zhu 27 82 2015 10.1017/neu.2014.43 Low-frequency repetitive Transcranial magnetic stimulation on Parkinson motor function: a meta-analysis of randomized controlled trials
PM R Wagle 8 356 2016 10.1016/j.pmrj.2015.08.009 Repetitive transcranial magnetic stimulation (rTMS) therapy in Parkinson disease: a meta-analysis
J Neurosci Strafella 21 157 2001 10.1523/JNEUROSCI.21-15-j0003.2001 Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus
Eur J Neurosci Strafella 22 2946 2005 10.1111/j.1460-9568.2005.04476.x Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study
J ECT Rabheru 28 39 2012 10.1097/YCT.0b013e3182455758 Maintenance electroconvulsive therapy (M-ECT) after acute response: examining the evidence for who, what, when, and how?
Brain Stimul Spagnolo 7 297 2014 10.1016/j.brs.2013.10.007 Excitatory deep repetitive transcranial magnetic stimulation with H-coil as add-on treatment of motor symptoms in Parkinson's disease: an open label, pilot study
Neurology Brys 87 1907 2016 10.1212/WNL.0000000000003279 Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease: a randomized trial
Neurology Shirota 80 1400 2013 10.1212/WNL.0b013e31828c2f66 Research Committee on rTMS Treatment of Parkinson's Disease. Supplementary motor area stimulation for Parkinson disease: a randomized controlled study
Neurology Benninger 76 601 2011 10.1212/WNL.0b013e31820ce6bb Intermittent theta-burst transcranial magnetic stimulation for treatment of Parkinson disease
Front Neurol Torres 6 210 2015 10.3389/fneur.2015.00210 Retrospective evaluation of deep transcranial magnetic stimulation as add- on treatment for Parkinson's disease
Neuroscientist Tang 23 82 2017 10.1177/1073858415618897 Repetitive transcranial magnetic stimulation of the brain: mechanisms from animal and experimental models
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.